Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with colon cancer

Gene

Volumn 508, Issue 2, 2012, Pages 229-232

  Mojtahedi, Zahra ^a   Mohmedi, Mona ^a   Rahimifar, Shahrzad ^a   Erfani, Nasrollah ^a   Hosseini, Seyed Vahid ^b   Ghaderi, Abbas ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Colorectal cancer; Inflammation; PD 1; SNP

Indexed keywords

GENOMIC DNA; PROGRAMMED DEATH 1 LIGAND 1;

ADULT; ARTICLE; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; COLON; COLONIC NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGRAMMED CELL DEATH 1 RECEPTOR; RECTAL NEOPLASMS; RECTUM;

EID: 84865756139     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.07.059     Document Type: Article

References (24)

1. Blank C., et al. Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy. Cancer Immunol. Immunother. 2005, 54:307-314.
2. Dalgleish A.G., O'Byrne K.J. Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer. Adv. Cancer Res. 2002, 84:231-276.
3. Dehaghani A.S., et al. PDCD1, CTLA-4 and p53 gene polymorphism and susceptibility to gestational trophoblastic diseases. J. Reprod. Med. 2009, 54:25-31.
4. Frattini M., et al. Different genetic features associated with colon and rectal carcinogenesis. Clin. Cancer Res. 2004, 10:4015-4021.
5. Gardner E.J. A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of the colon and rectum. Am. J. Hum. Genet. 1951, 3:167-176.
6. Gomes M., et al. Influence of functional genetic polymorphism (-590C/T) in non-small cell lung cancer (NSCLC) development: The paradoxal role of IL-4. Gene. 2012, 504:111-115.
7. Haghshenas M.R., et al. Program death 1 (PD1) haplotyping in patients with breast carcinoma. Mol. Biol. Rep. 2011, 38:4205-4210.
8. Haug U., et al. Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer. Genes Chromosomes Cancer 2012, 51:598-605.
9. Hua Z., et al. PD-1 polymorphisms are associated with sporadic breast cancer in Chinese Han population of Northeast China. Breast Cancer Res. Treat. 2011, 129:195-201.
10. Kline J., Gajewski T.F. Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer. Curr. Opin. Investig. Drugs 2010, 11:1354-1359.
11. Kong E.K., et al. A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum. 2005, 52:1058-1062.
12. Lee S.H., et al. Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population. Arthritis Res. Ther. 2006, 8:R163.
13. Liang M., Fu J. Triptolide inhibits interferon-gamma-induced programmed death-1-ligand 1 surface expression in breast cancer cells. Cancer Lett. 2008, 270:337-341.
14. Lin S.C., et al. Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum. 2004, 50:770-775.
15. Liu X., et al. Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population. Rheumatol. Int. 2011, 31:209-213.
16. Lubbe S.J., et al. Relationship between 16 susceptibility loci and colorectal cancer phenotype in 3146 patients. Carcinogenesis 2012, 33:108-112.
17. Mannie M.D. Immunological self/nonself discrimination: integration of self vs nonself during cognate T cell interactions with antigen-presenting cells. Immunol. Res. 1999, 19:65-87.
18. Masoompour S.M., et al. Cancer incidence in southern Iran, 1998-2002: results of population-based cancer registry. Cancer Epidemiol. 2011, 35:e42-e47.
19. Meng Q., et al. PDCD1 genes may protect against extraocular manifestations in Chinese Han patients with Vogt-Koyanagi-Harada syndrome. Mol. Vis. 2009, 15:386-392.
20. Potter J.D. Colorectal cancer: molecules and populations. J. Natl. Cancer Inst. 1999, 91:916-932.
21. Stanghellini V., et al. Gut microbiota and related diseases: clinical features. Intern. Emerg. Med Suppl 2010, 1:S57-S63.
22. Wang W., et al. PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells. Int. Immunol. 2009, 21:1065-1077.
23. Welsh M.M., et al. CTLA4 variants, UV-induced tolerance, and risk of non-melanoma skin cancer. Cancer Res. 2009, 69:6158-6163.
24. Zlobec I., et al. TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer. PLoS One 2010, 5:e14282.